US 12285419
Bupivacaine multivesicular liposome formulations and uses thereof
granted A61KA61K31/445A61K47/14
Quick answer
US patent 12285419 (Bupivacaine multivesicular liposome formulations and uses thereof) held by Pacira Pharmaceuticals, Inc. expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Pacira Pharmaceuticals, Inc.
- Grant date
- Tue Apr 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 38
- CPC classes
- A61K, A61K31/445, A61K47/14, A61K47/24, A61K47/28